| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 61 | 2023 | 930 | 4.770 |
Why?
|
| Hypertension | 41 | 2021 | 1058 | 4.690 |
Why?
|
| Cardiopulmonary Resuscitation | 14 | 2020 | 220 | 2.950 |
Why?
|
| Antihypertensive Agents | 22 | 2021 | 430 | 2.530 |
Why?
|
| Emergency Service, Hospital | 37 | 2020 | 1811 | 2.500 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 8 | 2020 | 61 | 2.430 |
Why?
|
| Blood Pressure | 24 | 2020 | 1539 | 2.380 |
Why?
|
| Ticlopidine | 8 | 2014 | 55 | 2.020 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 8 | 2015 | 78 | 1.790 |
Why?
|
| American Heart Association | 17 | 2020 | 264 | 1.630 |
Why?
|
| Heart Failure | 29 | 2020 | 1962 | 1.590 |
Why?
|
| Angioplasty, Balloon, Coronary | 18 | 2014 | 146 | 1.560 |
Why?
|
| Cardiology | 9 | 2020 | 259 | 1.520 |
Why?
|
| Cardiology Service, Hospital | 7 | 2020 | 28 | 1.500 |
Why?
|
| Aged | 139 | 2023 | 19119 | 1.490 |
Why?
|
| Asthma | 14 | 2016 | 2051 | 1.450 |
Why?
|
| Risk Assessment | 25 | 2023 | 2976 | 1.430 |
Why?
|
| Exercise Test | 13 | 2021 | 545 | 1.420 |
Why?
|
| Male | 213 | 2023 | 55730 | 1.410 |
Why?
|
| Female | 218 | 2023 | 59611 | 1.380 |
Why?
|
| Stroke | 14 | 2023 | 1015 | 1.360 |
Why?
|
| Humans | 320 | 2023 | 115039 | 1.350 |
Why?
|
| Middle Aged | 148 | 2023 | 26827 | 1.280 |
Why?
|
| Tomography, X-Ray Computed | 52 | 1995 | 2341 | 1.270 |
Why?
|
| Vascular Surgical Procedures | 3 | 2015 | 259 | 1.250 |
Why?
|
| Health Expenditures | 5 | 2023 | 171 | 1.200 |
Why?
|
| United States | 87 | 2023 | 12224 | 1.200 |
Why?
|
| Lower Extremity | 3 | 2015 | 337 | 1.190 |
Why?
|
| Sex Factors | 16 | 2017 | 1721 | 1.160 |
Why?
|
| Heart Arrest | 6 | 2020 | 289 | 1.150 |
Why?
|
| Defibrillators, Implantable | 11 | 2021 | 286 | 1.130 |
Why?
|
| Platelet Aggregation Inhibitors | 7 | 2014 | 399 | 1.130 |
Why?
|
| Quality of Health Care | 16 | 2013 | 573 | 1.080 |
Why?
|
| Guideline Adherence | 12 | 2015 | 492 | 1.080 |
Why?
|
| Cardiovascular Diseases | 11 | 2021 | 1729 | 1.060 |
Why?
|
| Medication Errors | 5 | 2011 | 89 | 1.020 |
Why?
|
| Stroke Volume | 15 | 2020 | 510 | 1.010 |
Why?
|
| Peripheral Arterial Disease | 3 | 2015 | 380 | 1.000 |
Why?
|
| Coronary Disease | 10 | 2011 | 347 | 1.000 |
Why?
|
| Retrospective Studies | 76 | 2023 | 12547 | 0.990 |
Why?
|
| Coronary Artery Disease | 9 | 2021 | 608 | 0.990 |
Why?
|
| Medication Adherence | 12 | 2021 | 537 | 0.980 |
Why?
|
| Risk Factors | 54 | 2021 | 8642 | 0.960 |
Why?
|
| Hospitalization | 27 | 2023 | 1754 | 0.940 |
Why?
|
| Myocardial Reperfusion | 12 | 2010 | 49 | 0.940 |
Why?
|
| Medical Order Entry Systems | 3 | 2011 | 41 | 0.920 |
Why?
|
| Medicare | 7 | 2023 | 666 | 0.920 |
Why?
|
| Adrenergic beta-Antagonists | 13 | 2017 | 294 | 0.900 |
Why?
|
| Patient Compliance | 14 | 2014 | 524 | 0.890 |
Why?
|
| Aged, 80 and over | 47 | 2023 | 6357 | 0.890 |
Why?
|
| Pharmacists | 5 | 2013 | 236 | 0.870 |
Why?
|
| Emergency Medicine | 6 | 2012 | 220 | 0.860 |
Why?
|
| Colorado | 38 | 2017 | 4089 | 0.850 |
Why?
|
| Proportional Hazards Models | 16 | 2017 | 1080 | 0.840 |
Why?
|
| Time Factors | 47 | 2020 | 6141 | 0.820 |
Why?
|
| Ambulatory Care | 6 | 2012 | 478 | 0.820 |
Why?
|
| Registries | 27 | 2017 | 1763 | 0.810 |
Why?
|
| Primary Prevention | 8 | 2019 | 171 | 0.790 |
Why?
|
| Electronic Health Records | 6 | 2017 | 799 | 0.790 |
Why?
|
| Practice Patterns, Physicians' | 9 | 2020 | 1177 | 0.780 |
Why?
|
| Death, Sudden, Cardiac | 7 | 2019 | 160 | 0.770 |
Why?
|
| Health Services | 2 | 2016 | 103 | 0.770 |
Why?
|
| Drug Prescriptions | 5 | 2011 | 239 | 0.760 |
Why?
|
| Outpatients | 4 | 2017 | 328 | 0.760 |
Why?
|
| Coronary Artery Bypass | 6 | 2021 | 196 | 0.750 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2017 | 180 | 0.750 |
Why?
|
| Quality of Life | 13 | 2016 | 2359 | 0.750 |
Why?
|
| Follow-Up Studies | 28 | 2021 | 4420 | 0.730 |
Why?
|
| Telemedicine | 5 | 2020 | 665 | 0.690 |
Why?
|
| Fee-for-Service Plans | 4 | 2023 | 83 | 0.690 |
Why?
|
| Thrombolytic Therapy | 9 | 2008 | 117 | 0.690 |
Why?
|
| Drug Monitoring | 5 | 2009 | 184 | 0.670 |
Why?
|
| Prosthesis Implantation | 3 | 2015 | 138 | 0.670 |
Why?
|
| Treatment Outcome | 43 | 2020 | 9122 | 0.670 |
Why?
|
| Clinical Pharmacy Information Systems | 3 | 2007 | 6 | 0.660 |
Why?
|
| Practice Guidelines as Topic | 15 | 2020 | 1398 | 0.660 |
Why?
|
| Adult | 91 | 2023 | 30655 | 0.650 |
Why?
|
| Self Care | 4 | 2020 | 351 | 0.650 |
Why?
|
| Cell Phone | 2 | 2021 | 77 | 0.650 |
Why?
|
| Incidence | 23 | 2017 | 2318 | 0.640 |
Why?
|
| Fractures, Bone | 16 | 1995 | 373 | 0.640 |
Why?
|
| Reminder Systems | 5 | 2015 | 161 | 0.630 |
Why?
|
| Primary Health Care | 8 | 2021 | 1512 | 0.630 |
Why?
|
| Coronary Angiography | 6 | 2018 | 307 | 0.620 |
Why?
|
| Managed Care Programs | 8 | 2015 | 134 | 0.620 |
Why?
|
| Heart Diseases | 7 | 2016 | 330 | 0.610 |
Why?
|
| Health Maintenance Organizations | 14 | 2013 | 94 | 0.600 |
Why?
|
| Chest Pain | 3 | 2007 | 81 | 0.590 |
Why?
|
| Electrocardiography | 15 | 2011 | 562 | 0.580 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2007 | 10 | 0.580 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2020 | 361 | 0.580 |
Why?
|
| Treatment Refusal | 6 | 2010 | 85 | 0.570 |
Why?
|
| Prehypertension | 3 | 2014 | 24 | 0.570 |
Why?
|
| Hospitals | 9 | 2009 | 582 | 0.550 |
Why?
|
| Bone Neoplasms | 12 | 1999 | 194 | 0.550 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2021 | 445 | 0.550 |
Why?
|
| Population Surveillance | 2 | 2017 | 392 | 0.550 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2018 | 486 | 0.540 |
Why?
|
| Health Care Reform | 2 | 2018 | 92 | 0.530 |
Why?
|
| Fibrinolytic Agents | 7 | 2010 | 233 | 0.530 |
Why?
|
| Comorbidity | 14 | 2018 | 1457 | 0.520 |
Why?
|
| Speech Recognition Software | 2 | 2015 | 11 | 0.520 |
Why?
|
| Evidence-Based Medicine | 9 | 2020 | 676 | 0.520 |
Why?
|
| Hospital Mortality | 13 | 2023 | 776 | 0.520 |
Why?
|
| Consensus | 7 | 2020 | 534 | 0.510 |
Why?
|
| Ventricular Function, Left | 8 | 2018 | 469 | 0.510 |
Why?
|
| Blood Pressure Determination | 8 | 2020 | 122 | 0.510 |
Why?
|
| Internship and Residency | 4 | 2022 | 941 | 0.500 |
Why?
|
| Cohort Studies | 35 | 2018 | 4904 | 0.500 |
Why?
|
| Volunteers | 1 | 2015 | 31 | 0.500 |
Why?
|
| Health Resources | 1 | 2016 | 122 | 0.500 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 814 | 0.480 |
Why?
|
| Multivariate Analysis | 21 | 2013 | 1435 | 0.480 |
Why?
|
| Intermittent Claudication | 1 | 2015 | 108 | 0.470 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2021 | 372 | 0.470 |
Why?
|
| Quality Improvement | 2 | 2021 | 953 | 0.470 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 250 | 0.460 |
Why?
|
| Drug-Eluting Stents | 5 | 2014 | 62 | 0.460 |
Why?
|
| Surveys and Questionnaires | 19 | 2016 | 4631 | 0.450 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2010 | 9 | 0.450 |
Why?
|
| Soft Tissue Neoplasms | 4 | 1997 | 90 | 0.450 |
Why?
|
| Myocardial Ischemia | 5 | 2007 | 236 | 0.450 |
Why?
|
| Prognosis | 18 | 2020 | 3334 | 0.450 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2013 | 38 | 0.440 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 90 | 0.440 |
Why?
|
| Case Management | 2 | 2013 | 62 | 0.440 |
Why?
|
| Diabetes Mellitus | 5 | 2013 | 906 | 0.440 |
Why?
|
| California | 7 | 2017 | 364 | 0.440 |
Why?
|
| Hyperkalemia | 1 | 2013 | 26 | 0.440 |
Why?
|
| Osteomyelitis | 6 | 1999 | 102 | 0.440 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2015 | 679 | 0.430 |
Why?
|
| Age Factors | 14 | 2020 | 2894 | 0.420 |
Why?
|
| Delivery of Health Care, Integrated | 6 | 2020 | 231 | 0.420 |
Why?
|
| Medicare Part C | 1 | 2013 | 25 | 0.420 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2013 | 64 | 0.420 |
Why?
|
| Mass Screening | 4 | 2014 | 1012 | 0.420 |
Why?
|
| Health Status | 11 | 2013 | 722 | 0.420 |
Why?
|
| Glucocorticoids | 2 | 2015 | 535 | 0.420 |
Why?
|
| Community Pharmacy Services | 1 | 2013 | 45 | 0.410 |
Why?
|
| Prospective Studies | 17 | 2016 | 6232 | 0.410 |
Why?
|
| Defibrillators | 1 | 2012 | 16 | 0.410 |
Why?
|
| Chlamydia trachomatis | 3 | 2006 | 36 | 0.410 |
Why?
|
| Ischemia | 1 | 2015 | 363 | 0.410 |
Why?
|
| Survival Rate | 9 | 2017 | 1646 | 0.410 |
Why?
|
| Emergencies | 6 | 2020 | 147 | 0.400 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 83 | 0.390 |
Why?
|
| Chlamydia Infections | 3 | 2006 | 65 | 0.390 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 268 | 0.390 |
Why?
|
| Adolescent | 37 | 2021 | 17862 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 4 | 2016 | 323 | 0.380 |
Why?
|
| Body Mass Index | 10 | 2017 | 1967 | 0.380 |
Why?
|
| Mortality | 5 | 2018 | 287 | 0.380 |
Why?
|
| Renal Insufficiency | 2 | 2011 | 136 | 0.380 |
Why?
|
| Muscular Diseases | 5 | 1993 | 106 | 0.380 |
Why?
|
| Electric Countershock | 3 | 2018 | 104 | 0.380 |
Why?
|
| Angina Pectoris | 4 | 2007 | 63 | 0.370 |
Why?
|
| Internet | 2 | 2013 | 600 | 0.370 |
Why?
|
| Cardiac Catheterization | 4 | 2019 | 535 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 1184 | 0.370 |
Why?
|
| Cholesterol, LDL | 4 | 2021 | 307 | 0.370 |
Why?
|
| Health Promotion | 2 | 2014 | 686 | 0.370 |
Why?
|
| Advanced Cardiac Life Support | 5 | 2020 | 23 | 0.370 |
Why?
|
| Survival Analysis | 10 | 2013 | 1211 | 0.360 |
Why?
|
| Delivery of Health Care | 4 | 2012 | 835 | 0.360 |
Why?
|
| Learning | 1 | 2014 | 352 | 0.360 |
Why?
|
| Healthcare Disparities | 4 | 2014 | 480 | 0.360 |
Why?
|
| Multimorbidity | 3 | 2020 | 33 | 0.360 |
Why?
|
| Emergency Medical Services | 9 | 2020 | 587 | 0.360 |
Why?
|
| Patient Selection | 4 | 2013 | 646 | 0.360 |
Why?
|
| Diabetic Angiopathies | 3 | 2015 | 244 | 0.350 |
Why?
|
| Physicians | 4 | 2023 | 772 | 0.350 |
Why?
|
| Health Care Costs | 6 | 2019 | 381 | 0.340 |
Why?
|
| Exercise Tolerance | 2 | 2008 | 213 | 0.340 |
Why?
|
| Patient Satisfaction | 5 | 2013 | 580 | 0.340 |
Why?
|
| Insurance, Health | 2 | 2021 | 244 | 0.340 |
Why?
|
| Ankle Injuries | 5 | 1995 | 73 | 0.340 |
Why?
|
| Logistic Models | 16 | 2012 | 1839 | 0.340 |
Why?
|
| Time and Motion Studies | 3 | 2007 | 21 | 0.330 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 75 | 0.330 |
Why?
|
| Acute Coronary Syndrome | 2 | 2010 | 254 | 0.330 |
Why?
|
| Metabolic Syndrome | 2 | 2009 | 324 | 0.330 |
Why?
|
| Prescription Drugs | 1 | 2011 | 116 | 0.330 |
Why?
|
| Health Services Research | 8 | 2013 | 371 | 0.320 |
Why?
|
| Patient Preference | 1 | 2011 | 169 | 0.320 |
Why?
|
| Image Processing, Computer-Assisted | 13 | 1991 | 698 | 0.320 |
Why?
|
| Clinical Protocols | 1 | 2010 | 234 | 0.320 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2018 | 278 | 0.320 |
Why?
|
| Safety Management | 2 | 2007 | 109 | 0.320 |
Why?
|
| Chi-Square Distribution | 9 | 2013 | 498 | 0.320 |
Why?
|
| Obesity | 3 | 2017 | 2524 | 0.310 |
Why?
|
| Information Services | 1 | 2008 | 45 | 0.310 |
Why?
|
| Risk Management | 1 | 2008 | 89 | 0.300 |
Why?
|
| Child, Preschool | 21 | 2017 | 9093 | 0.300 |
Why?
|
| Health Behavior | 3 | 2016 | 704 | 0.290 |
Why?
|
| Policy Making | 2 | 2008 | 81 | 0.290 |
Why?
|
| Sick Role | 2 | 2006 | 19 | 0.290 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 638 | 0.280 |
Why?
|
| Heart Function Tests | 2 | 2019 | 59 | 0.280 |
Why?
|
| Residence Characteristics | 3 | 2014 | 275 | 0.280 |
Why?
|
| Telephone | 4 | 2015 | 152 | 0.280 |
Why?
|
| Acetabulum | 7 | 1992 | 102 | 0.280 |
Why?
|
| Research Design | 8 | 2012 | 930 | 0.280 |
Why?
|
| Clinical Trials as Topic | 6 | 2009 | 937 | 0.280 |
Why?
|
| Research Report | 3 | 2016 | 75 | 0.280 |
Why?
|
| Crime Victims | 2 | 2008 | 81 | 0.280 |
Why?
|
| Minnesota | 5 | 2017 | 134 | 0.280 |
Why?
|
| Patient Discharge | 7 | 2023 | 767 | 0.280 |
Why?
|
| Organizational Policy | 1 | 2007 | 68 | 0.280 |
Why?
|
| Dyslipidemias | 3 | 2014 | 154 | 0.280 |
Why?
|
| Anticoagulants | 2 | 2014 | 546 | 0.270 |
Why?
|
| Hemorrhage | 4 | 2016 | 618 | 0.270 |
Why?
|
| Quality Assurance, Health Care | 5 | 2010 | 314 | 0.270 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2019 | 11 | 0.270 |
Why?
|
| Laboratories, Hospital | 1 | 2006 | 13 | 0.270 |
Why?
|
| Radiography | 11 | 2000 | 827 | 0.270 |
Why?
|
| Patient Participation | 3 | 2020 | 360 | 0.270 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2005 | 227 | 0.270 |
Why?
|
| Cross-Sectional Studies | 18 | 2016 | 4411 | 0.260 |
Why?
|
| Biomedical Research | 2 | 2008 | 585 | 0.260 |
Why?
|
| Age Distribution | 6 | 2013 | 340 | 0.260 |
Why?
|
| Warfarin | 2 | 2008 | 135 | 0.260 |
Why?
|
| Physician's Role | 1 | 2007 | 199 | 0.260 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 45 | 0.250 |
Why?
|
| Postoperative Complications | 4 | 2015 | 2150 | 0.250 |
Why?
|
| Preventive Health Services | 2 | 2007 | 135 | 0.250 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2008 | 154 | 0.250 |
Why?
|
| Child | 24 | 2017 | 18407 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 7 | 2014 | 544 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2021 | 1214 | 0.250 |
Why?
|
| Insurance Claim Review | 2 | 2016 | 67 | 0.250 |
Why?
|
| Malpractice | 2 | 2023 | 37 | 0.250 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 67 | 0.240 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 94 | 0.240 |
Why?
|
| Quality Indicators, Health Care | 5 | 2012 | 287 | 0.240 |
Why?
|
| Data Collection | 7 | 2008 | 623 | 0.230 |
Why?
|
| Angina, Unstable | 5 | 2009 | 72 | 0.230 |
Why?
|
| Health Facility Planning | 1 | 2003 | 1 | 0.230 |
Why?
|
| Community-Based Participatory Research | 3 | 2014 | 130 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 4 | 2003 | 1477 | 0.220 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 1081 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 2098 | 0.220 |
Why?
|
| Friends | 1 | 2004 | 46 | 0.220 |
Why?
|
| Models, Cardiovascular | 2 | 2023 | 179 | 0.220 |
Why?
|
| Rape | 1 | 2004 | 36 | 0.220 |
Why?
|
| Predictive Value of Tests | 8 | 2020 | 1812 | 0.220 |
Why?
|
| Odds Ratio | 9 | 2014 | 957 | 0.220 |
Why?
|
| Health Services Needs and Demand | 2 | 2009 | 245 | 0.220 |
Why?
|
| Ticks | 2 | 1993 | 12 | 0.210 |
Why?
|
| Hip Prosthesis | 4 | 1992 | 33 | 0.210 |
Why?
|
| Hand | 2 | 1997 | 134 | 0.210 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2016 | 499 | 0.210 |
Why?
|
| Joint Dislocations | 3 | 2012 | 56 | 0.210 |
Why?
|
| Patient Readmission | 5 | 2016 | 606 | 0.210 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 225 | 0.210 |
Why?
|
| Lyme Disease | 2 | 1993 | 32 | 0.210 |
Why?
|
| Bites and Stings | 2 | 1993 | 30 | 0.210 |
Why?
|
| Reproducibility of Results | 9 | 2021 | 2799 | 0.210 |
Why?
|
| Prevalence | 12 | 2014 | 2255 | 0.200 |
Why?
|
| Attitude of Health Personnel | 2 | 2008 | 976 | 0.200 |
Why?
|
| Overweight | 2 | 2017 | 474 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 1 | 2004 | 169 | 0.200 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2016 | 350 | 0.200 |
Why?
|
| Income | 2 | 2013 | 167 | 0.200 |
Why?
|
| Sickness Impact Profile | 3 | 2007 | 50 | 0.190 |
Why?
|
| Medicine | 1 | 2023 | 102 | 0.190 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1992 | 218 | 0.190 |
Why?
|
| Chronic Disease | 4 | 2020 | 1591 | 0.190 |
Why?
|
| Administration, Oral | 3 | 2016 | 730 | 0.190 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2017 | 76 | 0.190 |
Why?
|
| Insurance Carriers | 1 | 2021 | 9 | 0.190 |
Why?
|
| Drug Resistance | 2 | 2012 | 158 | 0.180 |
Why?
|
| Young Adult | 11 | 2021 | 10498 | 0.180 |
Why?
|
| Neonatology | 1 | 2020 | 17 | 0.180 |
Why?
|
| Regression Analysis | 5 | 2016 | 948 | 0.180 |
Why?
|
| Sacrum | 3 | 1991 | 64 | 0.180 |
Why?
|
| Physician-Patient Relations | 3 | 2020 | 463 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 245 | 0.180 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 125 | 0.180 |
Why?
|
| Interviews as Topic | 5 | 2013 | 584 | 0.170 |
Why?
|
| Forecasting | 1 | 2021 | 332 | 0.170 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 201 | 0.170 |
Why?
|
| Life Style | 3 | 2017 | 431 | 0.170 |
Why?
|
| Medical Errors | 2 | 2012 | 85 | 0.170 |
Why?
|
| Systole | 2 | 2017 | 171 | 0.170 |
Why?
|
| Cause of Death | 5 | 2018 | 364 | 0.170 |
Why?
|
| Disease Progression | 4 | 2015 | 2389 | 0.160 |
Why?
|
| Aspirin | 5 | 2014 | 324 | 0.160 |
Why?
|
| Text Messaging | 1 | 2021 | 154 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 1 | 2004 | 489 | 0.160 |
Why?
|
| Education, Medical, Continuing | 2 | 2014 | 119 | 0.160 |
Why?
|
| Withholding Treatment | 2 | 2010 | 69 | 0.160 |
Why?
|
| Urban Population | 3 | 2014 | 401 | 0.160 |
Why?
|
| Doxycycline | 2 | 1996 | 55 | 0.160 |
Why?
|
| Cross Infection | 1 | 2020 | 199 | 0.150 |
Why?
|
| Heart Rate | 3 | 2018 | 705 | 0.150 |
Why?
|
| Acute Disease | 9 | 2008 | 915 | 0.150 |
Why?
|
| Liability, Legal | 1 | 2018 | 38 | 0.150 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 249 | 0.150 |
Why?
|
| Disease Management | 2 | 2020 | 563 | 0.150 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 492 | 0.150 |
Why?
|
| Longitudinal Studies | 8 | 2018 | 2389 | 0.150 |
Why?
|
| Independent Living | 1 | 2018 | 84 | 0.150 |
Why?
|
| Censuses | 2 | 2014 | 18 | 0.150 |
Why?
|
| Hip Joint | 5 | 1991 | 131 | 0.150 |
Why?
|
| Cost Sharing | 1 | 1997 | 14 | 0.150 |
Why?
|
| Pediatrics | 2 | 2015 | 981 | 0.140 |
Why?
|
| Tibia | 3 | 1999 | 168 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2013 | 325 | 0.140 |
Why?
|
| Patient Safety | 3 | 2020 | 277 | 0.140 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2009 | 87 | 0.140 |
Why?
|
| Diastole | 1 | 2017 | 131 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 374 | 0.140 |
Why?
|
| Health Services Misuse | 2 | 2020 | 36 | 0.140 |
Why?
|
| Tuberculosis, Spinal | 2 | 1995 | 6 | 0.140 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 1996 | 4 | 0.130 |
Why?
|
| Knee Joint | 2 | 1999 | 324 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2020 | 515 | 0.130 |
Why?
|
| After-Hours Care | 2 | 2006 | 15 | 0.130 |
Why?
|
| Cysts | 1 | 1997 | 93 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 1996 | 25 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2016 | 128 | 0.130 |
Why?
|
| Hospitals, Veterans | 3 | 2006 | 244 | 0.130 |
Why?
|
| Prednisone | 1 | 2016 | 231 | 0.130 |
Why?
|
| Osteoma, Osteoid | 1 | 1995 | 4 | 0.130 |
Why?
|
| Humerus | 1 | 1995 | 40 | 0.130 |
Why?
|
| Paraplegia | 1 | 1995 | 52 | 0.130 |
Why?
|
| Femoral Neoplasms | 1 | 1995 | 7 | 0.130 |
Why?
|
| Thoracic Vertebrae | 1 | 1995 | 72 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 342 | 0.130 |
Why?
|
| Azithromycin | 1 | 1996 | 80 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.130 |
Why?
|
| Depression | 2 | 2014 | 1136 | 0.120 |
Why?
|
| Drug Interactions | 2 | 2007 | 347 | 0.120 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 68 | 0.120 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2014 | 5 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2009 | 575 | 0.120 |
Why?
|
| Selection Bias | 2 | 2005 | 33 | 0.120 |
Why?
|
| Poverty Areas | 1 | 2014 | 32 | 0.120 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2010 | 90 | 0.120 |
Why?
|
| Sarcoma, Ewing | 1 | 1995 | 64 | 0.120 |
Why?
|
| Contraceptives, Oral | 1 | 2014 | 25 | 0.120 |
Why?
|
| Social Welfare | 1 | 2014 | 20 | 0.120 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 211 | 0.120 |
Why?
|
| Thinness | 1 | 2015 | 87 | 0.120 |
Why?
|
| Angiography | 1 | 2015 | 177 | 0.120 |
Why?
|
| Veterans | 4 | 2018 | 1238 | 0.120 |
Why?
|
| Kidney | 3 | 2016 | 1186 | 0.120 |
Why?
|
| Leg | 1 | 1996 | 227 | 0.120 |
Why?
|
| Diagnosis, Differential | 8 | 1998 | 1355 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Pharmacoepidemiology | 1 | 2014 | 20 | 0.120 |
Why?
|
| Pelvis | 2 | 1992 | 90 | 0.120 |
Why?
|
| Shoulder Joint | 3 | 1998 | 159 | 0.110 |
Why?
|
| Canada | 2 | 2007 | 322 | 0.110 |
Why?
|
| Crowding | 2 | 2004 | 37 | 0.110 |
Why?
|
| Transition to Adult Care | 1 | 2015 | 63 | 0.110 |
Why?
|
| Creatinine | 2 | 2013 | 425 | 0.110 |
Why?
|
| Focus Groups | 3 | 2014 | 385 | 0.110 |
Why?
|
| Bone and Bones | 5 | 2000 | 280 | 0.110 |
Why?
|
| Capitation Fee | 1 | 2013 | 13 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 617 | 0.110 |
Why?
|
| Ossification, Heterotopic | 2 | 1993 | 14 | 0.110 |
Why?
|
| Computer-Assisted Instruction | 2 | 1991 | 64 | 0.110 |
Why?
|
| Drug Therapy, Combination | 3 | 2011 | 955 | 0.110 |
Why?
|
| Radiology | 2 | 2000 | 193 | 0.110 |
Why?
|
| Pain | 4 | 1999 | 709 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2015 | 641 | 0.110 |
Why?
|
| Potassium | 1 | 2013 | 128 | 0.110 |
Why?
|
| Family Practice | 2 | 2015 | 427 | 0.110 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 35 | 0.110 |
Why?
|
| Health Education | 3 | 2013 | 323 | 0.110 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 23 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 247 | 0.110 |
Why?
|
| Geography | 1 | 2013 | 180 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 147 | 0.100 |
Why?
|
| Confidence Intervals | 4 | 2010 | 306 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2012 | 332 | 0.100 |
Why?
|
| Models, Organizational | 2 | 2003 | 140 | 0.100 |
Why?
|
| Anthracyclines | 1 | 2012 | 41 | 0.100 |
Why?
|
| Mycosis Fungoides | 1 | 1992 | 61 | 0.100 |
Why?
|
| Cryptococcosis | 1 | 1992 | 23 | 0.100 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 71 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1321 | 0.100 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 119 | 0.100 |
Why?
|
| Vaccination | 2 | 2010 | 1205 | 0.100 |
Why?
|
| Depressive Disorder | 2 | 2007 | 333 | 0.100 |
Why?
|
| Inpatients | 2 | 2007 | 378 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 1865 | 0.100 |
Why?
|
| Bone Diseases | 3 | 1991 | 57 | 0.100 |
Why?
|
| Health Care Surveys | 5 | 2013 | 538 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2011 | 557 | 0.100 |
Why?
|
| Lymphoma | 1 | 1992 | 178 | 0.100 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2008 | 94 | 0.100 |
Why?
|
| Abscess | 2 | 1992 | 72 | 0.100 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 89 | 0.090 |
Why?
|
| Musculoskeletal Diseases | 1 | 1992 | 54 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2011 | 335 | 0.090 |
Why?
|
| Drug Utilization | 3 | 2012 | 167 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2014 | 405 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2019 | 3116 | 0.090 |
Why?
|
| Forms and Records Control | 1 | 2011 | 22 | 0.090 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1992 | 43 | 0.090 |
Why?
|
| Coronary Care Units | 2 | 2007 | 13 | 0.090 |
Why?
|
| Sporotrichosis | 1 | 1991 | 4 | 0.090 |
Why?
|
| Patient Education as Topic | 2 | 2017 | 682 | 0.090 |
Why?
|
| Parents | 3 | 2015 | 1189 | 0.090 |
Why?
|
| Patient-Centered Care | 2 | 2013 | 474 | 0.090 |
Why?
|
| Hospitals, Military | 1 | 2011 | 33 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2017 | 703 | 0.090 |
Why?
|
| Medical Laboratory Science | 1 | 2010 | 7 | 0.090 |
Why?
|
| Racism | 1 | 2013 | 102 | 0.090 |
Why?
|
| Cervical Vertebrae | 1 | 1992 | 106 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 300 | 0.090 |
Why?
|
| Physician Assistants | 2 | 2008 | 66 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 1992 | 76 | 0.090 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2010 | 38 | 0.090 |
Why?
|
| Femur | 2 | 1992 | 193 | 0.090 |
Why?
|
| Wrist | 1 | 1991 | 48 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 26 | 0.090 |
Why?
|
| Nurse Practitioners | 2 | 2008 | 102 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 1990 | 33 | 0.090 |
Why?
|
| Marfan Syndrome | 1 | 1990 | 43 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 2551 | 0.090 |
Why?
|
| Muscles | 2 | 1988 | 324 | 0.090 |
Why?
|
| Preoperative Care | 1 | 1992 | 318 | 0.090 |
Why?
|
| Parenting | 1 | 2013 | 250 | 0.090 |
Why?
|
| Prescriptions | 1 | 2010 | 60 | 0.090 |
Why?
|
| Washington | 2 | 2002 | 133 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 222 | 0.090 |
Why?
|
| Mummies | 1 | 1989 | 1 | 0.090 |
Why?
|
| Algorithms | 2 | 2014 | 1488 | 0.090 |
Why?
|
| Exercise | 3 | 2009 | 1644 | 0.080 |
Why?
|
| Bundle-Branch Block | 1 | 2009 | 29 | 0.080 |
Why?
|
| Chickenpox Vaccine | 1 | 2010 | 69 | 0.080 |
Why?
|
| Community Health Services | 2 | 2008 | 211 | 0.080 |
Why?
|
| Universities | 1 | 2012 | 339 | 0.080 |
Why?
|
| Pertussis Vaccine | 1 | 2009 | 21 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2010 | 132 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2023 | 3015 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 723 | 0.080 |
Why?
|
| Medication Therapy Management | 1 | 2010 | 67 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2009 | 27 | 0.080 |
Why?
|
| Whooping Cough | 1 | 2009 | 49 | 0.080 |
Why?
|
| Joints | 1 | 1989 | 84 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 1989 | 25 | 0.080 |
Why?
|
| Age of Onset | 1 | 2010 | 449 | 0.080 |
Why?
|
| Chickenpox | 1 | 2010 | 93 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 4 | 2016 | 604 | 0.080 |
Why?
|
| Shoulder Fractures | 1 | 1988 | 12 | 0.080 |
Why?
|
| Women's Health | 1 | 2011 | 271 | 0.080 |
Why?
|
| Health Literacy | 1 | 2011 | 166 | 0.080 |
Why?
|
| Anemia | 1 | 2010 | 144 | 0.080 |
Why?
|
| Health Surveys | 2 | 2009 | 443 | 0.080 |
Why?
|
| Patient Transfer | 2 | 2014 | 144 | 0.080 |
Why?
|
| Shoulder Injuries | 1 | 1988 | 52 | 0.080 |
Why?
|
| Prosthesis Design | 4 | 2016 | 285 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 665 | 0.080 |
Why?
|
| Psychometrics | 3 | 2007 | 608 | 0.080 |
Why?
|
| Utilization Review | 2 | 2005 | 34 | 0.080 |
Why?
|
| Probability | 4 | 2010 | 289 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2011 | 350 | 0.070 |
Why?
|
| Fibroma | 1 | 1988 | 21 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2008 | 115 | 0.070 |
Why?
|
| X-Ray Film | 2 | 2000 | 5 | 0.070 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
|
| Health Policy | 2 | 2008 | 333 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2010 | 315 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2007 | 63 | 0.070 |
Why?
|
| Diabetes Complications | 2 | 2006 | 212 | 0.070 |
Why?
|
| Arthralgia | 2 | 1998 | 50 | 0.070 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2007 | 242 | 0.070 |
Why?
|
| Infant | 10 | 2010 | 7945 | 0.070 |
Why?
|
| Software | 2 | 1990 | 537 | 0.070 |
Why?
|
| Risk | 4 | 2014 | 815 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 3 | 2000 | 57 | 0.070 |
Why?
|
| Thrombosis | 1 | 2010 | 301 | 0.070 |
Why?
|
| Diagnostic Errors | 2 | 2006 | 151 | 0.070 |
Why?
|
| Triage | 2 | 2006 | 192 | 0.070 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2006 | 33 | 0.070 |
Why?
|
| Analysis of Variance | 5 | 2007 | 1229 | 0.070 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2006 | 7 | 0.070 |
Why?
|
| Oregon | 1 | 2006 | 66 | 0.070 |
Why?
|
| Infant, Newborn | 6 | 2020 | 5040 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 120 | 0.070 |
Why?
|
| Anxiety | 1 | 2012 | 845 | 0.070 |
Why?
|
| Violence | 1 | 2008 | 200 | 0.070 |
Why?
|
| Uterine Cervicitis | 1 | 2006 | 7 | 0.070 |
Why?
|
| Program Development | 1 | 2008 | 346 | 0.070 |
Why?
|
| Emergency Treatment | 1 | 2007 | 113 | 0.070 |
Why?
|
| Hospitals, Special | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2014 | 458 | 0.070 |
Why?
|
| Cardiac Care Facilities | 1 | 2006 | 13 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2018 | 1821 | 0.070 |
Why?
|
| Lipids | 1 | 2009 | 586 | 0.070 |
Why?
|
| Patient Admission | 2 | 2004 | 175 | 0.070 |
Why?
|
| Biopsy | 4 | 1999 | 1046 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 1879 | 0.070 |
Why?
|
| Office Visits | 3 | 2015 | 79 | 0.060 |
Why?
|
| Chronology as Topic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2008 | 256 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2007 | 201 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 2006 | 62 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2005 | 77 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 182 | 0.060 |
Why?
|
| Computer Graphics | 3 | 1991 | 42 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 1992 | 758 | 0.060 |
Why?
|
| Sample Size | 1 | 2005 | 112 | 0.060 |
Why?
|
| Decision Making | 4 | 2016 | 782 | 0.060 |
Why?
|
| Length of Stay | 2 | 2007 | 950 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2013 | 897 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 89 | 0.060 |
Why?
|
| Child Health Services | 1 | 2007 | 176 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2007 | 234 | 0.060 |
Why?
|
| Echocardiography | 2 | 2019 | 557 | 0.060 |
Why?
|
| Computer Simulation | 2 | 1991 | 880 | 0.060 |
Why?
|
| Pharmacokinetics | 1 | 2004 | 25 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2006 | 253 | 0.060 |
Why?
|
| Benchmarking | 1 | 2005 | 161 | 0.060 |
Why?
|
| Melanoma | 1 | 1990 | 622 | 0.060 |
Why?
|
| Hospital Bed Capacity | 1 | 2003 | 21 | 0.060 |
Why?
|
| Stents | 1 | 2007 | 476 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 513 | 0.060 |
Why?
|
| Syndrome | 4 | 2006 | 337 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 1989 | 102 | 0.060 |
Why?
|
| Cooperative Behavior | 2 | 2020 | 383 | 0.050 |
Why?
|
| Linear Models | 3 | 2011 | 776 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2006 | 477 | 0.050 |
Why?
|
| Patient Care | 1 | 2023 | 103 | 0.050 |
Why?
|
| Peer Review | 1 | 2003 | 43 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2014 | 22 | 0.050 |
Why?
|
| Data Display | 2 | 1993 | 19 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2002 | 52 | 0.050 |
Why?
|
| Hirudins | 2 | 2014 | 46 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 1857 | 0.050 |
Why?
|
| Neoplasms | 2 | 2013 | 2106 | 0.050 |
Why?
|
| Insurance Coverage | 2 | 2015 | 201 | 0.050 |
Why?
|
| Spinal Diseases | 3 | 1993 | 44 | 0.050 |
Why?
|
| Mental Health | 2 | 2004 | 559 | 0.050 |
Why?
|
| Ankle Joint | 3 | 1993 | 154 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2014 | 331 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2014 | 184 | 0.050 |
Why?
|
| Pelvic Bones | 3 | 1995 | 127 | 0.050 |
Why?
|
| Heparin | 2 | 2014 | 222 | 0.050 |
Why?
|
| Surgery Department, Hospital | 1 | 2000 | 21 | 0.050 |
Why?
|
| Demography | 3 | 2007 | 261 | 0.050 |
Why?
|
| Italy | 1 | 2020 | 92 | 0.040 |
Why?
|
| Alcoholism | 1 | 2007 | 716 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 70 | 0.040 |
Why?
|
| Decision Support Techniques | 3 | 2009 | 351 | 0.040 |
Why?
|
| Lions | 1 | 1999 | 2 | 0.040 |
Why?
|
| Biomechanical Phenomena | 3 | 1993 | 675 | 0.040 |
Why?
|
| Triglycerides | 2 | 2014 | 471 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 1990 | 2201 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2012 | 448 | 0.040 |
Why?
|
| Medical Records | 3 | 2007 | 155 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 185 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 77 | 0.040 |
Why?
|
| Sacroiliac Joint | 2 | 1991 | 30 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 2019 | 77 | 0.040 |
Why?
|
| Diabetic Foot | 1 | 1999 | 22 | 0.040 |
Why?
|
| Pain Management | 2 | 2012 | 289 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 1006 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 1237 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2014 | 935 | 0.040 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2019 | 51 | 0.040 |
Why?
|
| Rotation | 2 | 1996 | 113 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 99 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 1999 | 65 | 0.040 |
Why?
|
| Fractures, Ununited | 2 | 1989 | 24 | 0.040 |
Why?
|
| Pregnancy | 2 | 2007 | 5519 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2000 | 152 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 1375 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 164 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2014 | 668 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2000 | 232 | 0.040 |
Why?
|
| Acromion | 1 | 1997 | 7 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 275 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 1127 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2000 | 1715 | 0.040 |
Why?
|
| Deductibles and Coinsurance | 1 | 1997 | 9 | 0.040 |
Why?
|
| Joint Diseases | 3 | 1999 | 59 | 0.040 |
Why?
|
| Hip | 2 | 1988 | 46 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 1989 | 241 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2000 | 217 | 0.030 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2016 | 16 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2007 | 222 | 0.030 |
Why?
|
| Health Services Accessibility | 3 | 2011 | 765 | 0.030 |
Why?
|
| Decision Trees | 1 | 1996 | 81 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2008 | 1132 | 0.030 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1995 | 2 | 0.030 |
Why?
|
| Accidents, Occupational | 1 | 1995 | 14 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2010 | 678 | 0.030 |
Why?
|
| Urban Health | 1 | 1995 | 73 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 116 | 0.030 |
Why?
|
| Fracture Healing | 1 | 1995 | 76 | 0.030 |
Why?
|
| Government Programs | 1 | 2015 | 22 | 0.030 |
Why?
|
| Bladder Exstrophy | 1 | 1995 | 15 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 196 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 161 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2014 | 20 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2015 | 130 | 0.030 |
Why?
|
| ROC Curve | 3 | 2004 | 447 | 0.030 |
Why?
|
| Clinical Coding | 1 | 2014 | 19 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2008 | 316 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 1995 | 128 | 0.030 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2014 | 27 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 224 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2020 | 899 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 719 | 0.030 |
Why?
|
| Hip Dislocation, Congenital | 3 | 1991 | 47 | 0.030 |
Why?
|
| Communication Barriers | 1 | 2014 | 89 | 0.030 |
Why?
|
| Necrosis | 2 | 1992 | 210 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2014 | 51 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 1993 | 18 | 0.030 |
Why?
|
| Proteinuria | 1 | 2013 | 77 | 0.030 |
Why?
|
| User-Computer Interface | 2 | 2010 | 143 | 0.030 |
Why?
|
| History, Ancient | 1 | 2013 | 48 | 0.030 |
Why?
|
| Lipoma | 1 | 1993 | 16 | 0.030 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1992 | 8 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2013 | 45 | 0.030 |
Why?
|
| Erythema | 1 | 1992 | 25 | 0.030 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2013 | 97 | 0.030 |
Why?
|
| Bone Cysts | 1 | 1992 | 11 | 0.030 |
Why?
|
| Trastuzumab | 1 | 2012 | 89 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2013 | 72 | 0.030 |
Why?
|
| Poverty | 1 | 1995 | 443 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 941 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 2012 | 57 | 0.030 |
Why?
|
| Diuretics | 1 | 2012 | 66 | 0.030 |
Why?
|
| Drug Costs | 1 | 2013 | 91 | 0.030 |
Why?
|
| Lymphedema | 1 | 1992 | 20 | 0.020 |
Why?
|
| Models, Structural | 2 | 1991 | 37 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 109 | 0.020 |
Why?
|
| Cellulitis | 1 | 1992 | 45 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1992 | 119 | 0.020 |
Why?
|
| Ohio | 1 | 2012 | 136 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 873 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2012 | 119 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 221 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3419 | 0.020 |
Why?
|
| Database Management Systems | 1 | 1991 | 48 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 1991 | 29 | 0.020 |
Why?
|
| Hand Deformities, Congenital | 1 | 1991 | 8 | 0.020 |
Why?
|
| Sporothrix | 1 | 1991 | 3 | 0.020 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Awards and Prizes | 1 | 2012 | 56 | 0.020 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1993 | 122 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 1991 | 13 | 0.020 |
Why?
|
| Lung Diseases, Fungal | 1 | 1991 | 13 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2006 | 633 | 0.020 |
Why?
|
| Aspergillosis | 1 | 1991 | 23 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1991 | 60 | 0.020 |
Why?
|
| Pyridines | 1 | 2014 | 425 | 0.020 |
Why?
|
| Hand Injuries | 1 | 1991 | 33 | 0.020 |
Why?
|
| Wrist Joint | 1 | 1991 | 59 | 0.020 |
Why?
|
| Hip Dislocation | 1 | 1991 | 50 | 0.020 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 1992 | 131 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 412 | 0.020 |
Why?
|
| Splenic Diseases | 1 | 1990 | 5 | 0.020 |
Why?
|
| Tarsal Bones | 1 | 1990 | 32 | 0.020 |
Why?
|
| Fibula | 1 | 1990 | 41 | 0.020 |
Why?
|
| Calcinosis | 2 | 1990 | 242 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 26 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 1990 | 127 | 0.020 |
Why?
|
| Arthrography | 1 | 1989 | 22 | 0.020 |
Why?
|
| Sternoclavicular Joint | 1 | 1989 | 9 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 205 | 0.020 |
Why?
|
| Osteoradionecrosis | 1 | 1989 | 2 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 94 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2013 | 297 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1990 | 54 | 0.020 |
Why?
|
| Tibial Fractures | 1 | 1990 | 70 | 0.020 |
Why?
|
| Femoral Neck Fractures | 1 | 1989 | 22 | 0.020 |
Why?
|
| Foot Injuries | 1 | 1989 | 36 | 0.020 |
Why?
|
| Obstetrics | 1 | 2011 | 146 | 0.020 |
Why?
|
| Ankle | 1 | 1989 | 70 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2009 | 82 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 602 | 0.020 |
Why?
|
| Security Measures | 1 | 2008 | 7 | 0.020 |
Why?
|
| Epiphyses, Slipped | 1 | 1988 | 4 | 0.020 |
Why?
|
| Weapons | 1 | 2008 | 9 | 0.020 |
Why?
|
| Emergency Nursing | 1 | 2008 | 19 | 0.020 |
Why?
|
| Foot | 1 | 1989 | 103 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 1991 | 356 | 0.020 |
Why?
|
| Gynecology | 1 | 2011 | 163 | 0.020 |
Why?
|
| Femur Head | 1 | 1988 | 33 | 0.020 |
Why?
|
| Observer Variation | 2 | 2000 | 298 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 1988 | 5 | 0.020 |
Why?
|
| Educational Status | 1 | 1990 | 412 | 0.020 |
Why?
|
| Bacteroides Infections | 1 | 1988 | 1 | 0.020 |
Why?
|
| Shoulder | 1 | 1988 | 85 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1989 | 127 | 0.020 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1988 | 12 | 0.020 |
Why?
|
| Ilium | 1 | 1988 | 27 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2008 | 72 | 0.020 |
Why?
|
| Methods | 1 | 1987 | 59 | 0.020 |
Why?
|
| Musculoskeletal System | 1 | 1988 | 44 | 0.020 |
Why?
|
| Carcinoma | 1 | 1989 | 199 | 0.020 |
Why?
|
| Nomograms | 1 | 2007 | 41 | 0.020 |
Why?
|
| Personnel Turnover | 1 | 2007 | 27 | 0.020 |
Why?
|
| Hip Fractures | 1 | 1988 | 75 | 0.020 |
Why?
|
| Myositis | 1 | 1987 | 44 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 387 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1988 | 100 | 0.020 |
Why?
|
| Suburban Population | 1 | 2007 | 16 | 0.020 |
Why?
|
| Metals | 1 | 1988 | 107 | 0.020 |
Why?
|
| Orthopedics | 1 | 1989 | 122 | 0.020 |
Why?
|
| Midwifery | 1 | 2008 | 45 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1990 | 259 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1993 | 795 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1988 | 132 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2007 | 89 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 26 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1988 | 139 | 0.020 |
Why?
|
| Reperfusion | 1 | 2006 | 37 | 0.020 |
Why?
|
| Disclosure | 1 | 2007 | 101 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 1987 | 138 | 0.020 |
Why?
|
| Wound Healing | 1 | 1989 | 259 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 72 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1989 | 212 | 0.020 |
Why?
|
| Skin | 1 | 1991 | 659 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 1993 | 921 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2007 | 222 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2006 | 72 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1987 | 219 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 748 | 0.020 |
Why?
|
| Research | 1 | 2008 | 395 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 231 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 2004 | 4 | 0.020 |
Why?
|
| Refusal to Participate | 1 | 2004 | 6 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2006 | 99 | 0.020 |
Why?
|
| Palliative Care | 1 | 1990 | 639 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1353 | 0.010 |
Why?
|
| Safety | 1 | 2006 | 297 | 0.010 |
Why?
|
| Nurses | 1 | 2006 | 144 | 0.010 |
Why?
|
| Animals | 3 | 1999 | 31867 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 746 | 0.010 |
Why?
|
| Operations Research | 1 | 2003 | 2 | 0.010 |
Why?
|
| Bed Occupancy | 1 | 2003 | 10 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 122 | 0.010 |
Why?
|
| Total Quality Management | 1 | 2003 | 62 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 292 | 0.010 |
Why?
|
| Health Planning | 1 | 2003 | 46 | 0.010 |
Why?
|
| Ambulances | 1 | 2002 | 50 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2003 | 124 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 287 | 0.010 |
Why?
|
| Microcomputers | 2 | 1991 | 14 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2003 | 271 | 0.010 |
Why?
|
| Teleradiology | 1 | 2000 | 4 | 0.010 |
Why?
|
| Communication | 1 | 2006 | 744 | 0.010 |
Why?
|
| Group Processes | 1 | 2001 | 53 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 2000 | 33 | 0.010 |
Why?
|
| Aspergillus niger | 1 | 1999 | 8 | 0.010 |
Why?
|
| Animals, Zoo | 1 | 1999 | 12 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2000 | 275 | 0.010 |
Why?
|
| Video Recording | 1 | 2000 | 145 | 0.010 |
Why?
|
| Ventilation | 1 | 1999 | 32 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 163 | 0.010 |
Why?
|
| Markov Chains | 1 | 2000 | 114 | 0.010 |
Why?
|
| Technetium | 1 | 1999 | 8 | 0.010 |
Why?
|
| Gangrene | 1 | 1999 | 6 | 0.010 |
Why?
|
| Air Microbiology | 1 | 1999 | 40 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1999 | 115 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2001 | 351 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1989 | 169 | 0.010 |
Why?
|
| Chondroma | 1 | 1998 | 1 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1999 | 323 | 0.010 |
Why?
|
| Rotator Cuff | 1 | 1997 | 43 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 797 | 0.010 |
Why?
|
| Femur Head Necrosis | 2 | 1988 | 9 | 0.010 |
Why?
|
| Smoking | 1 | 2004 | 1392 | 0.010 |
Why?
|
| Sick Leave | 1 | 1995 | 12 | 0.010 |
Why?
|
| Philadelphia | 1 | 1995 | 46 | 0.010 |
Why?
|
| Occupations | 1 | 1995 | 36 | 0.010 |
Why?
|
| Workers' Compensation | 1 | 1995 | 27 | 0.010 |
Why?
|
| Pelvimetry | 1 | 1995 | 2 | 0.010 |
Why?
|
| Epispadias | 1 | 1995 | 3 | 0.010 |
Why?
|
| Industry | 1 | 1995 | 65 | 0.010 |
Why?
|
| Cloaca | 1 | 1995 | 48 | 0.010 |
Why?
|
| Employment | 1 | 1995 | 139 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 1995 | 139 | 0.010 |
Why?
|
| Cost of Illness | 1 | 1995 | 254 | 0.010 |
Why?
|
| Computer Terminals | 1 | 1993 | 5 | 0.010 |
Why?
|
| Osteotomy | 1 | 1995 | 152 | 0.010 |
Why?
|
| Rupture | 1 | 1992 | 95 | 0.010 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 1991 | 12 | 0.010 |
Why?
|
| Casts, Surgical | 1 | 1992 | 31 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 58 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 1992 | 79 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1993 | 247 | 0.010 |
Why?
|
| Knee Injuries | 1 | 1992 | 89 | 0.010 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 1990 | 3 | 0.010 |
Why?
|
| Traction | 1 | 1991 | 15 | 0.010 |
Why?
|
| Femoral Fractures | 1 | 1991 | 67 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1990 | 17 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 1990 | 14 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1990 | 20 | 0.010 |
Why?
|
| Antiemetics | 1 | 1990 | 32 | 0.010 |
Why?
|
| Narcotics | 1 | 1990 | 44 | 0.010 |
Why?
|
| Nausea | 1 | 1990 | 102 | 0.010 |
Why?
|
| Back | 1 | 1990 | 10 | 0.010 |
Why?
|
| Pneumocystis | 1 | 1990 | 6 | 0.010 |
Why?
|
| Neutropenia | 1 | 1990 | 125 | 0.010 |
Why?
|
| Nerve Block | 1 | 1990 | 62 | 0.010 |
Why?
|
| Ischium | 1 | 1989 | 5 | 0.010 |
Why?
|
| Sternum | 1 | 1989 | 17 | 0.010 |
Why?
|
| Fever | 1 | 1990 | 280 | 0.010 |
Why?
|
| Analgesics | 1 | 1990 | 157 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1989 | 30 | 0.010 |
Why?
|
| Clavicle | 1 | 1989 | 31 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1993 | 558 | 0.010 |
Why?
|
| Fracture Fixation | 1 | 1989 | 77 | 0.000 |
Why?
|
| Enterobacter | 1 | 1987 | 7 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1989 | 442 | 0.000 |
Why?
|
| Thigh | 1 | 1987 | 53 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1989 | 167 | 0.000 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1987 | 32 | 0.000 |
Why?
|
| Lung | 1 | 1999 | 3595 | 0.000 |
Why?
|
| Social Support | 1 | 1990 | 528 | 0.000 |
Why?
|
| Reoperation | 1 | 1989 | 519 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1990 | 636 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1987 | 127 | 0.000 |
Why?
|
| Models, Biological | 1 | 1991 | 1636 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1987 | 336 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1986 | 172 | 0.000 |
Why?
|
| Brain | 1 | 1991 | 2379 | 0.000 |
Why?
|